Cargando…
Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial
BACKGROUND: Glioblastoma is a rapidly proliferating tumor. Patients bear an inferior prognosis with a median survival time of 14-16 months. Proliferation and repopulation are a major resistance promoting factor for conventionally fractionated radiotherapy. Tumor-Treating-Fields (TTFields) are an ant...
Autores principales: | Guberina, N., Pöttgen, C., Kebir, S., Lazaridis, L., Scharmberg, C., Lübcke, W., Niessen, M., Guberina, M., Scheffler, B., Jendrossek, V., Jabbarli, R., Pierscianek, D., Sure, U., Schmidt, T., Oster, C., Hau, P., Grosu, A. L., Stuschke, M., Glas, M., Nour, Y., Lüdemann, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168823/ https://www.ncbi.nlm.nih.gov/pubmed/32307022 http://dx.doi.org/10.1186/s13014-020-01521-7 |
Ejemplares similares
-
Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF‐phase I/II trial
por: Nour, Youness, et al.
Publicado: (2021) -
Location of Recurrences after Trimodality Treatment for Glioblastoma with Respect to the Delivered Radiation Dose Distribution and Its Influence on Prognosis
por: Guberina, Nika, et al.
Publicado: (2023) -
Respiration-controlled radiotherapy in lung cancer: Systematic evaluation of the optimal application practice
por: Guberina, M., et al.
Publicado: (2023) -
How about Levetiracetam in Glioblastoma? An Institutional Experience and Meta-Analysis
por: Jabbarli, Ramazan, et al.
Publicado: (2021) -
Machine-learning-based prediction of the effectiveness of the delivered dose by exhale-gated radiotherapy for locally advanced lung cancer: The additional value of geometric over dosimetric parameters alone
por: Guberina, Nika, et al.
Publicado: (2023)